51 results
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
8 May 24
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
7:01am
and payment obligations; compliance with anti-corruption, sanctions and trade control laws; environmental risks; and the impact of sustainability issues
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
31 Jan 24
Results of Operations and Financial Condition
7:00am
claims; failure to comply with complex Medicare, Medicaid and other governmental programs reporting and payment obligations; compliance with anti … -corruption, sanctions and trade control laws; environmental risks; and the impact of Environmental, Social and Governance issues;
the impact of the state
8-K
EX-99.1
zf2t8 fapd9wje
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
EX-99.1
d4tcq3yn
2 Aug 23
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
m91r8
10 May 23
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
10h2rguqhijl9t
3 Nov 22
Key financial highlights and outlook
7:00am
8-K
EX-99.1
7pk9se 15r
26 Jul 22
Key financial highlights and outlook
4:56pm
8-K
EX-99.1
5cqdsj57yd
3 May 22
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
tjefa
9 Feb 22
Results of Operations and Financial Condition
7:00am
8-K
EX-1.1
sxtrlt9
4 Nov 21
Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,000,000,000 of Sustainability-Linked Senior Notes
4:44pm